Log in
A+ A A-

Marketplace

European and Brazilian Cardiologists Cooperate to Reduce Cardiovascular Deaths

Mortality rates from CVD in Brazil are the highest in Latin America

 

esc-in-brasilThe European Society of Cardiology (ESC) is to deliver an educational programme at the 66th Annual Congress of the Brazilian Society of Cardiology.

This meeting is the largest cardiology conference in Latin America and will be held in Porto Alegre, Brazil from 16 to 19 September 2011. The Brazilian Society of Cardiology is an affiliated society of the ESC and has around 13,000 members.

Sophia Antipolis, 12 September 2011: Against a background of high mortality rates from cardiovascular disease (CVD) in Brazil, the European Society of Cardiology (ESC) is to deliver an educational programme at the 66th Annual Congress of the Brazilian Society of Cardiology.

  • Written by European Society of Cardiology
  • Category: Cardiovascular
  • Hits: 1652

Non communicable Diseases at the Centre of UN Discussions

The European Chronic Disease Alliance (ECDA) welcomes the UN High Level Meeting on Non Communicable Diseases (NCDs) to address the world biggest killers

 

The European Chronic Disease Alliance (ECDA)1 welcomes the UN High Level Meeting on Non Communicable Diseases (NCDs) to address the world's biggest killers.  “It is a memorable day in the history of public health. Discussing non communicable diseases at the UN table gives a strong sense of the burden it represents to human kind and the recognition that NCDs is a challenge for all nations in the world2”, declared Professor Michel Komajda, President of the European Society of Cardiology, an active member of the ECDA.

Hemodynamic Results After Transcatheter Aortic Valve Implantation (TAVI): Up to 3 Years Follow-up of 338 Patients After CoreValve Implantation

Topics: Valvular Heart Diseases

tavi-1Paris, France – Aug. 30, 2011: Since 2007 Transcatheter Aortic Valve Implantation (TAVI) has become an alternative treatment for elderly patients with severe aortic stenosis at high risk for surgical aortic valve replacement.

At present, durability and hemodynamic performance of transcatheter aortic valves remain unclear. Our single center data of the German Heart Center in Munich demonstrates a sustained improvement of hemodynamic performance up to 3 years after CoreValve implantation.

  • Written by Mrs Opitz, Anke (Muenchen, Germany)
  • Category: Cardiovascular
  • Hits: 1471

Eating chocolate cuts risk of heart disease

chocolate

Eating high levels of chocolate could be associated with a significant reduction in the risk of certain cardiovascular disorders, reveals Cambridge research published in the British Medical Journal this week.

 

The researchers compiled a systematic review of seven studies using data from 114,000 patients and found that people who consumed the most chocolate had a 37 per cent lower risk of developing heart disease and a 29 per cent lower risk of suffering a stroke than those who consumed less chocolate.

The studies looked at the consumption of dark chocolate as well as milk chocolate, chocolate drinks and other chocolate confectionaries.

Although the analysis suggests a certain benefit to eating higher quantities of chocolate, the findings still need to be interpreted with caution, in particular because commercially available chocolate is very calorific and eating too much of it could in itself lead to weight gain, which increases various health risks.

  • Written by University of Cambridge
  • Category: Cardiovascular
  • Hits: 1781

Assessing the Most Appropriate Duration of Dual Antiplatelet Therapy After Coronary Stenting: the PRODIGY Study

Hot Line III - Acute Coronary Syndromes

Topics: Percutaneous Cardiovascular Intervention (PCI)

Paris, France, 30 August: A randomised multicentre open-label study evaluating the efficacy and safety of prolonged antiplatelet therapy in patients with coronary disease has found that 24 months' duration of dual therapy is no better than six months DAPT in preventing adverse cardiac events

However, the prolonging Dual antiplatelet treatment after Grading stent-induced Intimal hyperplasia study (PRODIGY) also found a consistently greater risk of haemorrhage in the 24-month dual therapy group according to all prespecified bleeding definitions, including the recently proposed Bleeding Academic Research Consortium classification. The need for transfusion was also increased in the longer treatment group.

  • Written by Doctor Valgimigli, Marco (Ferrara, Italy)
  • Category: Cardiovascular
  • Hits: 1314

39°F

New York

Fair

Humidity: 20%

Wind: 7 mph

  • 5 Apr 2016 43°F 29°F
  • 6 Apr 2016 49°F 44°F